SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened community interest driven by high short interest and rising borrow rates, fueling speculation about an impending short squeeze ahead of its upcoming earnings report. Investors are actively discussing the stock's potential for a significant breakout, emphasizing institutional acquisitions and the firm's role in the evolving enterprise AI market.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is seeing heavy retail interest and positive price momentum as investors speculate on the potential for its proprietary electro-optic polymer technology to become a critical component in next-generation AI and high-speed data center infrastructure. The community is actively debating the company's path toward commercialization and watching for potential institutional partnerships or licensing deals that could validate its long-term growth potential.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is facing significant downward pressure as investors react to a lowered full-year bookings forecast, with the company attributing the slowdown to disruptive new age-verification and child safety measures. The community is sharply divided, with bulls viewing the dip as a long-term accumulation opportunity despite the near-term friction, while bears focus on the potential for continued user growth headwinds and regulatory risks.

AIOS Tech, Inc. is an investment holding company, which engages in the provision of financing solutions to small- and mid-size enterprises. The company was founded on May 29, 2012 and is headquartered in Shanghai, China.

AIOS Tech Inc. - Ordinary Shares - Class A

AIOS Tech Inc.

AIOS Tech Inc. is generating intense community interest driven by micro-float momentum and speculative trading dynamics often seen in low-float, high-volatility setups. Traders are actively debating the sustainability of the stock's recent price action, with some highlighting potential for short squeezes while others warn of risks related to debt and dilution.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending following the announcement of a massive $2.8 billion AI infrastructure expansion with Yotta Data Services, which has reignited intense community debate regarding the company's valuation, contract execution risk, and short-interest dynamics. While bullish investors point to the significant project pipeline and strategic partnerships as signs of a pending breakout, bears continue to express skepticism regarding the company's revenue recognition, lack of formal guidance, and history of unfulfilled promises.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors digest news of potential FDA leadership changes, with the community closely tracking rumors of a former company VP being considered for a key regulatory role. The optimism is fueled by strong HOPE-3 Phase 3 clinical data for its lead therapy, leading many to believe that the path to approval is nearing completion despite recent price volatility caused by speculative short-selling.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is trending following the announcement of a 1.5 billion dollar acquisition of the Long Ridge Energy & Power facility, a strategic pivot designed to scale the company's AI and high-performance computing infrastructure. The community is actively debating the merits of this transition, with bulls highlighting the potential for significant long-term growth and new revenue streams, while skeptical bears emphasize historical underperformance, management criticism, and the risks associated with mounting debt.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is currently generating significant investor interest due to strong revenue growth and expectations for its upcoming earnings report. The community is actively discussing the company's AI-driven marketing capabilities, while some express frustration over price volatility and perceived market manipulation.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing intense volatility and institutional attention as investors debate its role in the AI datacenter 'supercycle' versus concerns over its current valuation and lack of profitability. The community remains sharply divided, with bulls pointing to expanding production capacity and high-speed transceiver demand while shorts anticipate a potential correction due to the stock's rapid appreciation and insider activity.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is currently trending as investors weigh the company's recent earnings beat and strategic capital moves against ongoing concerns regarding high cash burn and dilution risk. Community discussion is heavily focused on the company's long-term potential tied to the R2 platform ramp-up and production milestones, with investors debating whether current price levels present a buying opportunity or a signal of deeper volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MediciNova, Inc. (NASDAQ:MNOV) Sees Large Decrease in Short Interest

MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) saw a large decline in short interest in April. As of April 15th, there was short interest totaling 168,023 shares, a decline of 16.4% from the March...

MediciNova, Inc. (NASDAQ:MNOV) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven ratings firms that are currently covering the firm...

MediciNova (NASDAQ:MNOV) Share Price Crosses Above Two Hundred Day Moving Average   - Here's Why

MediciNova (NASDAQ:MNOV) Shares Pass Above 200 Day Moving Average - Should You Sell...

MediciNova (NASDAQ:MNOV) Shares Cross Above 200 Day Moving Average - Here's What Happened

MediciNova (NASDAQ:MNOV) Stock Crosses Above 200-Day Moving Average - Should You Sell...

Maxim Group Reiterates "Buy" Rating for MediciNova (NASDAQ:MNOV)

Maxim Group reaffirmed a "buy" rating and set a $6.00 price objective on shares of MediciNova in a report on Monday...

MediciNova, Inc. (NASDAQ:MNOV) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) have received a consensus rating of "Moderate Buy" from the six brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, two have i...

MediciNova (NASDAQ:MNOV) Raised to "Hold" at Zacks Research

Zacks Research raised MediciNova to a "hold" rating in a research note on Tuesday...

Q1 Earnings Estimate for MediciNova Issued By HC Wainwright

MediciNova, Inc. (NASDAQ:MNOV - Free Report) - Research analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for MediciNova in a research report issued on Monday, March 16th...

MediciNova (NASDAQ:MNOV) Now Covered by HC Wainwright

HC Wainwright initiated coverage on shares of MediciNova in a research note on Monday. They issued a "buy" rating and a $10.00 price target on the stock...

MediciNova (NASDAQ:MNOV) Stock Passes Above 200-Day Moving Average - Should You Sell?

MediciNova (NASDAQ:MNOV) Stock Passes Above 200 Day Moving Average - Should You Sell...

MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.

MNOV
Medicinova Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MNOV News

MNOVMedicinova Inc